The San Francisco-based company, which was founded in 2014, offers a solution that lets organizations integrate data from various sources (like EMR systems and claims files) into a single platform.
Venrock has closed its eighth fund, raising $450 million for future technology and healthcare investments. According to Venrock Partner Bryan Roberts, it's a size that will optimize performance; "not too big and not too small, but just about right."
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
With private and corporate financing rounds in excess of $400 million, the allure of a biotech IPO has drastically declined in 2016. Will that phenomenon roll into 2017 -- or are the public markets poised to rebound? One investor has some opinions.
Boston-based Third Rock Ventures announced Monday that it had closed its largest fund to date, raising $616 million for new investments in neurology, immunology, genetic disorders and more.